Page 159 - Profile's Stock Exchange Handbook - 2021 Issue 3
P. 159

Profile’s Stock Exchange Handbook: 2021 – Issue 3                       JSE – MED
                                                  Fixed Ass     4 052  4 358  3 524  3 590  3 703
             Mediclinic International plc         Inv in Assoc   171  181   193   357  465
        MED                                       Inv & Loans    12     9    10    7     8
       ISIN: GB00B8HX8Z88
       SHORT: MEDICLINIC                          Def Tax Asset  34    22    22   22    21
       CODE: MEI                                  Tot Curr Ass  1 232  1 213  1 091  961  1 069
       REG NO: 08338604                           Ord SH Int    2 849  2 890  3 151  3 286  4 086
       FOUNDED: 1983                              Minority Int   118  113   115   87    78
       LISTED: 1986                               LT Liab       3 021  3 182  2 576  2 445  2 668
                                                  Tot Curr Liab  684  769   584   525  590
        NATURE OF BUSINESS:                       PER SHARE STATISTICS (cents per share)
        Mediclinic is a diversified international private healthcare  EPS (ZARc)  195.96  - 814.18  - 369.21 - 1 148.57  570.71
        services group, founded in South Africa in 1983, with divisions  HEPS-C (ZARc)  204.48  504.64  515.09  475.27  570.71
        inSwitzerland,SouthernAfrica(SouthAfricaandNamibia),and  Pct chng p.a.  - 59.5  - 2.0  8.4  - 16.7  - 7.0
        the United Arab Emirates. The Group’s core purpose is to  Tr 5yr av grwth %  - 15.4  1.9  5.7  79.3  46.0
        enhance the quality of life. Its vision is to be the partner of choice  DPS (ZARc)  -  60.83  145.41  139.39  133.92
                                                                                  4.1
                                                                            4.3
        that people trust for all their healthcare needs.  Pct chng p.a.  - 100.0  - 58.2  10.3  11.8  - 13.9
                                                                                       13.0
                                                                      - 3.5
                                                   Tr 5yr av grwth %
                                                                - 32.7
        Mediclinic is focused on providing specialist-orientated,  NAV PS (ZARc)  7 872.19 8 655.36 8 372.73 7 581.02 9 277.81
        multi-disciplinary services across the continuum of care in  3 Yr Beta  0.73  1.05  1.19  0.98  1.38
        such a way that the Group will be regarded as the most  Price High  7 019  8 043  12 023  15 261  21 803
        respected and trusted provider of healthcare services by  Price Low  5 250  5 157  5 199  8 810  11 384
        patients, medical practitioners, funders and regulators of  Price Prd End  5 815  5 729  5 699  10 015  11 918
        healthcare in each of its markets.        RATIOS        2.66  - 9.96  - 3.98  - 14.05  5.84
                                                  Ret on SH Fnd
        At 31 March 2021, Mediclinic comprised 74 hospitals, 5  Ret On Tot Ass  0.78  - 4.58  - 2.02  - 7.47  3.27
        sub-acute and specialised hospitals and 2 mental health facili-  Oper Pft Mgn  6.98  - 5.97  2.76  - 10.01  13.17
        ties, 18 day case clinics, and 18 outpatient clinics. Hirslanden  D:E  1.05  1.11  0.53  0.50  0.40
        operated 17 hospitals and four day case clinics in Switzerland  Int Cover  2.83  n/a  n/a  n/a  5.40
        with more than 1 900 inpatient beds; Mediclinic Southern  Current Ratio  1.80  1.58  1.87  1.83  1.81
                                                                  -
                                                                     - 13.38
                                                                           - 2.20
                                                                                 - 8.17
        Africa operations included 50 hospitals (three of which in  Div Cover  NUMBER OF EMPLOYEES: 33 140  3.92
        Namibia), 5 sub-acute hospitals, 2 mental health facilities and  DIRECTORS: Beale Dame I K (Chair, ind ne, UK),
        12 day caseclinics(fourofwhich operated by Intercare) across  van der Merwe Dr C A (CEO), Myburgh P J (CFO),
        South Africa, and more than 8 600 inpatient beds; and  Al HashimiDrMY(ind ne, Emirati),
        Mediclinic Middle East operated seven hospitals, two day case  Durand JJ(ne),
                                                               Grieve JA(snr ind ne, UK and Swiss),
        clinics and 18 outpatient clinics with more than 900 inpatient  Harvey Dr F A H (ind ne, UK), Meintjes D P (ne),
        beds in the UAE. In addition, under a management contract  Oswald Dr A (ind ne, Swiss), Petersen T D (ind ne),
        Mediclinic Middle East operates one hospital in Abu Dhabi  Singer TD(ind ne, UK), Weiner S R (ind ne, USA),
                                                               Uys P J (alt)
        and will open a 200-bed hospital in the Kingdom of Saudi  Scan the QR code to  POPULAR BRAND NAMES: ER24, Hirslanden,
        Arabia in mid-2022.                        visit our website  Medical  Innovations,  Mediclinic,  Mediclinic
        The Company’s primary listing is on the London Stock   Middle East, MHR
        Exchange (“LSE”) in the United Kingdom, with secondary  POSTAL ADDRESS: PO Box 456, Stellenbosch, 7599
                                                  EMAIL: info@mediclinic.com
        listings on the JSE in South Africa and the Namibian Stock  WEBSITE: www.mediclinic.com
        Exchange in Namibia.                      TELEPHONE: 021-809-6500  FAX: 086-532-2557
        Mediclinic also holds a 29.9% interest in Spire Healthcare  COMPANY SECRETARY: Link Company Matters Ltd.
        Group plc, a leading private healthcare group based in the  TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
        United Kingdom and listed on the LSE.     SPONSORS: Morgan Stanley & Co International plc (UK), Rand Merchant
                                                   Bank (A division of FirstRand Bank Ltd. (SA)), Simonis Storm Securities
        Mediclinic also has many strategic partnerships, including:  (Pty) Ltd., UBS Investment Bank (UK)
        Switzerland                               AUDITORS: PwC LLP
        *Medbase                                  CALENDAR               Expected     Status
        *Various leading private and public healthcare institutions  Annual General Meeting  27 Jul 2021  Confirmed
        South Africa                              Next Interim Results   Nov 2021  Unconfirmed
        *Medical Innovations - procurer and manufacturer of hospital  Next Final Results  May 2022  Unconfirmed
        equipment                                 CAPITAL STRUCTURE   AUTHORISED     ISSUED
        *MHR - recruitment of temporary and permanent staff across  MEI  Ords 10p ea  -  737 243 810
        all sectors of the healthcare industry    DISTRIBUTIONS [GBPp]
                                                                                Pay
                                                                        Ldt
        *ER24 - emergency medical transport services  Ords 10p ea    3 Dec 19  17 Dec 19  Amt
                                                  Interim No 13
                                                                                       3.20
        *Icon Oncology – cancer treatment provider
                                                  Final No 12        11 Jun 19  29 Jul 19  4.70
        United Arab Emirates                      Interim No 11      4 Dec 18  18 Dec 18  3.20
        *Bourn Hall MENA – UAE-based fertility centre  Final No 10   12 Jun 18  30 Jul 18  4.70
        *Various leading tertiary institutions    LIQUIDITY: Jun21 Ave 5m shares p.w., R276.4m(31.9% p.a.)
        Kingdom of Saudi Arabia                             40 Week MA        MEDICLINIC
        *Al Murjan Group – leading business investment group
       SECTOR: HlthCare—HtlhCare—HlthCarePrvdrs—HlthCareFacilities
       MAJOR ORDINARY SHAREHOLDERS as at 03 Jun 2021                                   17953
         Remgro                           44.56%
         Public Investment Corporation SOC Ltd.  9.66%                                 14815
         Genesis Investment Management LLP  5.01%
                                                                                       11676
       FINANCIAL STATISTICS
       (GBP million)  Mar 21  Mar 20  Mar 19  Mar 18  Mar 17                           8538
                     Final  Final  Final  Final  Final
       Turnover      2 995  3 083  2 932  2 876  2 749                                 5400
                                                     2016  |  2017  |  2018  |  2019  |  2020  |
       Op Inc         209  - 184  81  - 288  362
       NetIntPd(Rcvd)  95   83    57   85    67   Recent Announcements
       Tax            25    24    - 7  - 5   64   Thursday, 24 June 2021: Notice is hereby given that the Company’s
       Minority Int   11    21    21   18    14    annual broad-based black economic empowerment compliance
       Att Inc        68   - 320  - 151  - 492  229
       TotCompIncLoss  - 29  - 151  - 22  - 723  665  report (“compliance report”) in terms of section 13G(2) of the
       Hline Erngs-CO  71  198   211   203  229    South African Broad-Based Black Economic Empowerment Act,
                                                   No. 53 of 2003, as amended (the “B-BBEE Act”).
                                               157
   154   155   156   157   158   159   160   161   162   163   164